In force Publication date 13 Apr 15
The Impact of gender and race on the ergogenic and pharmacokinetic effects of chronic high dose short acting 2-Agonist use
Resource description
Project Title: The Impact of gender and race on the ergogenic and pharmacokinetic effects of chronic high dose short acting 2-Agonist use
Researchers: G. Whyte, J. Dickinson, J. Burniston
Institution: Liverpool John Moore University, UK
Year accepted: 2010
Summary: The current research team currently has a WADA grant investigating one-off high doses of short-acting 2-agonists on performance in endurance running and football specific trials across race and gender. At present there are no investigations examining the chronic use of short or long acting inhaled 2-agonists on performance.